医学
多学科方法
临床试验
医学物理学
临床肿瘤学
重症监护医学
内科学
癌症
社会科学
社会学
作者
Hannah G. McDonald,Emily B. Cassim,Megan M. Harper,Erin E. Burke,Emily F. Marcinkowski,Michael J. Cavnar,Prakash K. Pandalai,Joseph Kim
标识
DOI:10.1016/j.soc.2022.07.003
摘要
Investigator-initiated trials (IITs) are designed by principal investigators who identify important, unaddressed clinical gaps and opportunities to answer these questions through clinical trials. Surgical oncologists are poised to lead IITs due to their multidisciplinary clinical practice and substantial research background. The process of developing, organizing, and implementing IITs is multifaceted and involves important steps including (but not limited to) navigating regulatory requirements, obtaining funding, and meeting enrollment targets. Here, the authors explore the steps, methodology, and barriers of IIT development by surgical oncologists and highlight the importance of IITs in oncology.
科研通智能强力驱动
Strongly Powered by AbleSci AI